ACTINIUM PHARMACEUTICALS
Live / Applied — New application — not yet assigned to an examiner (as of 12 Mar 2026)
What this means for you
Not registered yet, but its 12 Mar 2026 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 99698608
- Mark type
- Design + words
- Filed
- 12 Mar 2026
- Attorney of record
- Michael E. Dukes
Goods and services
- Class 005 — Pharmaceuticals: medicinal preparations for use in oncology; pharmaceutical preparations and substances for the treatment of oncological related diseases and disorders; radiopharmaceutical antibody preparations
- Class 042 — Scientific and technological services: Scientific research and development; Pharmaceutical research and development; Research and development of antibodies; Research and development of medicines; Research and development of new products; Research and development of conjugated antibodies; Research and development in the field of pharmaceuticals; Research and development of advanced learning technologies and teaching methods; Research and development of pharmaceuticals for the treatment of age-related diseases and cancer
Owner
- Actinium Pharmaceuticals, Inc., New York, NY, US
Prosecution history
- 12 Mar 2026 — APPLICATION FILING RECEIPT MAILED
- 12 Mar 2026 — NEW APPLICATION ENTERED